Key Takeaways
- • Cornell University's $10.7 billion endowment is not participating in the surge of secondary sales affecting peer institutions, according to CIO Ken Miranda, who stated he finds the volume of PE stake dispositions among endowments "surprising."
- • The secondaries market posted a record $160 billion in deal volume in 2024, driven primarily by endowments and institutional LPs forced to raise liquidity as equity and bond portfolio values declined, leaving them overweighted in illiquid private markets.
- • Cornell maintains disciplined rebalancing protocols independent of market volatility, adhering to preset allocation ranges and only selling positions when they exceed targets—avoiding the forced liquidations at discounts seen at Yale, Harvard, and other major endowments.
- • Major universities including Yale ($41 billion endowment) and Harvard are actively selling billions in private equity fund stakes through secondaries channels to address liquidity constraints and fund new commitments amid sluggish IPO and M&A activity.
- • The disparity in endowment strategies highlights divergent approaches to liquidity management: Cornell's steady-state rebalancing versus peers' reactive secondary sales, raising questions about the underlying motivations driving the widespread portfolio shifts across Ivy League institutions.
Summary
The booming secondaries market—which recorded $160 billion in deal volume during 2024—has been substantially fueled by endowments forced to liquidate private equity positions at discounts to raise cash. However, Cornell University's Chief Investment Officer Ken Miranda expressed skepticism about the scope of these sales, telling Institutional Investor that the volume of secondary transactions among peer institutions is "surprising" and that Cornell itself has not faced comparable liquidity pressures.
Miranda's comments reveal a strategic divergence among elite universities. While Yale, with its $41 billion endowment, and Harvard have entered the secondaries market to sell billions in PE fund stakes, Cornell has maintained its prescribed rebalancing discipline without deviating from its long-term allocation targets. The key distinction lies in portfolio construction and liquidity management. Cornell's $10.7 billion endowment adheres to a framework that allows it to rebalance positions when they drift beyond preset allocation ranges, with the team selling portions of overweight positions only after assessing whether market corrections may self-correct. "We've stuck to our guns. We rebalance when we should and have plenty of liquidity," Miranda stated.
The broader endowment sector has faced acute liquidity challenges as public market valuations declined, causing private equity allocations—which maintain stable or rising valuations—to become disproportionately large relative to diversified portfolios. This mismatch has driven many institutions toward the secondaries market, where they can exit aging fund positions, albeit typically at discounts to net asset value. Miranda's observation suggests that either Cornell's initial allocation discipline or superior cash flow management has insulated the institution from the desperation that has characterized peer secondary sales.
The divergence underscores a critical debate within institutional investment management: whether heavy secondaries activity reflects deliberate portfolio optimization or forced asset sales masquerading as strategic rebalancing. With IPO markets shuttered, M&A activity sluggish, and liquidity constrained across the institutional base, the secondary market has emerged as a critical pressure valve—yet Cornell's ability to avoid significant participation suggests that disciplined rebalancing protocols and robust liquidity reserves can mitigate the need for distressed sales that characterize current market conditions.
Miranda's comments reveal a strategic divergence among elite universities. While Yale, with its $41 billion endowment, and Harvard have entered the secondaries market to sell billions in PE fund stakes, Cornell has maintained its prescribed rebalancing discipline without deviating from its long-term allocation targets. The key distinction lies in portfolio construction and liquidity management. Cornell's $10.7 billion endowment adheres to a framework that allows it to rebalance positions when they drift beyond preset allocation ranges, with the team selling portions of overweight positions only after assessing whether market corrections may self-correct. "We've stuck to our guns. We rebalance when we should and have plenty of liquidity," Miranda stated.
The broader endowment sector has faced acute liquidity challenges as public market valuations declined, causing private equity allocations—which maintain stable or rising valuations—to become disproportionately large relative to diversified portfolios. This mismatch has driven many institutions toward the secondaries market, where they can exit aging fund positions, albeit typically at discounts to net asset value. Miranda's observation suggests that either Cornell's initial allocation discipline or superior cash flow management has insulated the institution from the desperation that has characterized peer secondary sales.
The divergence underscores a critical debate within institutional investment management: whether heavy secondaries activity reflects deliberate portfolio optimization or forced asset sales masquerading as strategic rebalancing. With IPO markets shuttered, M&A activity sluggish, and liquidity constrained across the institutional base, the secondary market has emerged as a critical pressure valve—yet Cornell's ability to avoid significant participation suggests that disciplined rebalancing protocols and robust liquidity reserves can mitigate the need for distressed sales that characterize current market conditions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.